This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
1h Free Analyst TimeSpeak directly to the analyst to clarify any post sales queries you may have.
According to the research report, “Global Wound Care Management Market Outlook, 2028” the market is anticipated to cross USD 30 Billion by 2028, increasing from USD 22.98 Billion in 2022. The market is expected to grow with 5.56% CAGR by 2023-28. The global population is aging, leading to a higher incidence of chronic wounds, such as pressure ulcers and diabetic ulcers. Elderly individuals are more susceptible to chronic health conditions, which require wound management, thereby driving market growth. In addition to that, the increasing prevalence of chronic diseases, including diabetes, obesity, and vascular diseases, has resulted in a greater number of patients with chronic wounds. Managing these wounds is essential, spurring demand for wound care products and services. The number of surgical procedures, both elective and non-elective, continues to increase globally. Surgical wounds require post-operative wound care and management, contributing to the demand for wound care products. Also, ongoing advancements in wound care technology have led to the development of innovative products and therapies. Examples include negative pressure wound therapy (NPWT) devices, advanced wound dressings, and bioactive wound care products. These innovations improve the effectiveness and efficiency of wound management. Traumatic injuries, such as burns, accidents, and combat-related injuries, necessitate specialized wound care. Advances in trauma care and a greater emphasis on military and civilian trauma response have contributed to the demand for wound management products. The growth in healthcare expenditure, particularly in emerging markets, has allowed for greater investment in wound care infrastructure, research, and development, supporting market expansion. The adoption of telemedicine and remote monitoring technologies has enabled healthcare providers to remotely assess and manage wounds. This has become especially important during the COVID-19 pandemic, reducing the need for in-person visits and supporting the continuity of wound care. Furthermore, the establishment of wound care clinics and specialized wound care centers has improved access to comprehensive wound care services. These facilities focus on advanced wound care techniques, promoting market growth.
There is a growing awareness among patients and healthcare professionals about the importance of proper wound care. Patients are more proactive in seeking timely wound treatment, and healthcare providers are increasingly emphasizing evidence-based wound management practices. Many companies are incorporating various strategies such as product launches, mergers & acquisitions, collaboration, and expansion to meet the demand. For instance, in October 2021, Medline Industries launched Post-Acute Infection Prevention Program. This will be a consultative program and aims to help the company increase its product penetration in the general population. Similarly, in 2021, Mölnlycke announced the launch of a new U.K. distribution center. This helped the company strengthen customer access to quality Mölnlycke products. Adoption of inorganic strategies such as partnerships by key market players is expected to drive the global wound care market growth over the forecast period. For Instance, in November 2022, InfuSystem Holdings, Inc, a leading national healthcare provider, and Sanara MedTech Inc, a medical equipment manufacturer, announced the partnership that focused on delivering a complete wound care solution targeted at lowering the cost of care, enable InfuSystem to offer innovative products including Cork Medical LLC’s negative pressure improving patient outcomes, and providing satisfaction to patients. This partnership is expected will wound therapy (NPWT) devices and supplies, and Sanara’s advanced wound care product line to customers. Government authorities are taking initiatives to introduce new products for better wound care management. Thus, increasing number of product approvals is expected to drive the growth of market over the forecast period. For instance, in September 2021, Omeza, a healthcare company, announced it had received an approval from the U.S. Food and Drug Administration for Omeza collagen matrix, a wound care matrix comprised of hydrolyzed fish collagen for the management of chronic wound care including partial and full-thickness wounds, diabetic ulcers, chronic vascular ulcers, surgical wounds, and draining wounds.
The Asia-Pacific market is expected to account for a large revenue share over other regional markets in the global wound care market during the forecast period.
The Asia-Pacific region is home to a substantial and rapidly aging population. As people age, they are more susceptible to chronic conditions like diabetes and vascular diseases, which often lead to chronic wounds. The increasing elderly population has driven the demand for wound management products and services. The prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases has been on the rise in many APAC countries. These conditions are known to increase the risk of chronic wounds, necessitating wound management. APAC has witnessed a surge in surgical procedures, both elective and non-elective. Surgical wounds require proper post-operative care and management, fueling the demand for wound care products and services. Many countries in the APAC region have been increasing their healthcare expenditure, resulting in improved healthcare infrastructure and access to advanced wound care. Rising disposable incomes have allowed patients to opt for better wound care options. Several APAC governments have launched initiatives to improve wound care services and standards. These initiatives often include training programs for healthcare professionals and investments in wound care research. In countries like India and China, efforts have been made to improve healthcare access in rural areas. This has extended wound care services to previously underserved populations. In addition to that, some APAC countries have become popular destinations for medical tourism. Patients travel from other regions for medical procedures, including wound care, due to the availability of high-quality healthcare at competitive prices. Besides, the rising focus of market players on expanding their operating networks in emerging countries of Asia Pacific is further expected to propel the regional market’s growth.
The advanced wound care products segment is expected to account for largest revenue share in the global wound care market during the forecast period.
Based on product, the wound care market has been segmented into advanced wound dressings, surgical wound care, traditional wound care, and wound therapy devices. Among them, advanced wound care segment is anticipated to dominate the market by the end of the forecast period. The rise in the number of burn cases is one of the key elements contributing to this domination. For instance, according to the American Burn Association, burn injuries in the United States are treated medically. Burn patients are said to experience the greatest rates of infection-related consequences. Innovative items called advanced wound care solutions have been developed for the welfare of those with wound-related conditions like diabetes and ulcers. Advanced wound care products are cutting-edge. Consequently, it is projected that a rising incidence rate will increase demand for conventional wound care products. Advanced wound care solutions are recommended by doctors for quick wound healing. The major purposes of advanced wound management products are the treatment of chronic and non-healing wounds. Another contributing factor is the growing recurrence of ongoing injuries such as diabetic foot ulcers, venous leg ulcers, and intense injuries like severe and traumatic wounds. This is expected to increase the number of individuals receiving continuous wound care, driving further growth in the market. In summary, the Advanced Wound Care Market is experiencing significant growth, and this can be attributed to the increase in chronic and acute wounds, the global geriatric population, and the growing rate of diabetes patients. These factors are driving the need for more advanced wound care treatment, making this market an attractive opportunity for businesses and investors looking to capitalize on this growing demand.
Based on the application, chronic wounds application segment is projected to dominate the global wound care management market by 2028.
The market segment for chronic wounds, which presently holds the highest share, is expected to increase significantly over the forecast period. The dominance is ascribed to the rise in the number of patients with leg ulcers, vascular ulcers, pressure ulcers, and diabetic foot ulcers as well as the rising cost of treating these conditions. The elderly population is expected to expand in number, and chronic wounds such as arterial ulcers, venous pressure ulcers, diabetic ulcers, and others are also expected to become more common. A chronic wound that develops in diabetic people is called a diabetic foot ulcer. The increasing geriatric population, along with the rising prevalence of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds is expected to drive the segment growth. For instance, according to the obtained data, the United States population aged 65 and above was expected to be 54.1 Million in 2019, which is about 19% of the U.S. population. This population increased by about 36% from 2009-2019. It is projected to reach 80 million by 2040, and 95 Million by 2060. Furthermore, the number of people suffering from varicose vein ailment in the U.S. is increasing year-on-year. According to the Journal of the American Heart Association, approximately 23% i.e., 1 in every 4 U.S. residents suffer from varicose vein ailment. An increase in the number of varicose veins patients may lead to the development of venous leg ulcers, thus, driving the market growth. On the other hand, the rise in traumatic wound and burn cases is a key element in the market's expansion. Surgical wound infections, better outcomes, more patient satisfaction, and shorter hospital stays are only a few of the many advantages of acute wounds. Advanced wound care therapy uses acute wound care products the most since they encourage the formation of new tissue. Patients with complicated burn wounds and diabetic wounds are treated with these acute wound care products.
Hospitals and clinics end users have dominated the global wound care management market from the historic period 2017-2022.
The hospitals & clinics segment is expected to account for largest revenue share over the forecast period due to increasing hospital admissions owing to chronic conditions, as well as a rise in prevalence of hospital-acquired pressure ulcers. Surgical wound care dressings as well as NPWT are primarily intended for hospital usage and are not appropriate for homecare. In addition, diabetic patients' lengthier hospital stays in this end-use segment rises demand for advanced wound care solutions. Hospitals are also regarded as significant stakeholders in wound care since they have long-term agreements with suppliers. These factors are expected to drive market growth in this segment over the forecast period. On the other hand, the home healthcare segment is expected to register a rapid revenue growth rate during the forecast period. Home healthcare wound care items were in high demand during the 2020 COVID pandemic. Development of single-use NPWT devices transformed wound care in homecare settings. These devices are portable, light, easily operable, and do not require canisters. Furthermore, cost-effectiveness of such wound-care therapy assists patients to choose homecare settings over doctor visits at the hospital. Thus, with a rise in elderly population as well as assisted living facilities, this segment is expected to grow throughout the forecast period.
Market Drivers
- Aging Population: The global population is aging, leading to an increased prevalence of chronic diseases like diabetes and cardiovascular conditions. Older individuals are more prone to chronic wounds, such as pressure ulcers and diabetic foot ulcers. This demographic shift is driving the demand for advanced wound management solutions and products, including innovative dressings, negative pressure wound therapy devices, and bioactive wound care products.
- Technological Advancements: Advances in wound care technologies are a significant driver for the wound management market. These advancements include the development of smart dressings embedded with sensors to monitor wound healing progress, the use of 3D printing for customized wound dressings, and the application of regenerative medicine techniques like stem cell therapy and tissue engineering for wound healing. These innovations not only enhance patient outcomes but also create new opportunities for market growth.
Market Challenges
- Cost Constraints: The high cost of advanced wound care products and therapies can be a significant challenge. While these treatments can provide better outcomes and shorter healing times, they can also strain healthcare budgets. Access to advanced wound care may be limited in some regions, leading to disparities in wound management outcomes.
- Antimicrobial Resistance: As the use of antimicrobial agents in wound care becomes more prevalent, there is a growing concern about antimicrobial resistance. Overuse of antibiotics and antimicrobial dressings can lead to the development of drug-resistant bacteria, making wound infections harder to treat. Striking a balance between infection control and responsible antimicrobial use is a challenge for healthcare providers and the wound care industry.
Market Trends
- Telemedicine and Remote Monitoring: The adoption of telemedicine and remote monitoring technologies has accelerated, especially in the wake of the COVID-19 pandemic. In wound management, telemedicine enables healthcare professionals to assess wounds, provide guidance on care, and monitor healing progress remotely. This trend improves patient convenience and reduces the need for frequent in-person visits.
- Personalized Wound Care: Wound management is increasingly moving towards personalized approaches. This involves tailoring treatments based on a patient's unique characteristics, such as genetics, wound type, and comorbidities. Advances in genomics and precision medicine are allowing for more targeted therapies and better outcomes.
Covid-19 Impacts
The pandemic disrupted global supply chains, affecting the production and distribution of wound management products. Lockdowns, restrictions on international trade, and increased demand for healthcare supplies strained the availability of wound care products, leading to supply shortages in some regions. Healthcare systems around the world had to shift their priorities to address the COVID-19 crisis. Hospitals and healthcare providers diverted resources, including personnel and facilities, to deal with the surge in COVID-19 cases. As a result, some non-essential or elective wound management procedures and treatments were postponed or canceled. Patients who required wound care treatments, such as post-surgical wound care or chronic wound management, faced delays due to the pandemic. Fear of infection and limited access to healthcare facilities led some individuals to avoid seeking medical attention for their wounds, potentially exacerbating their conditions. Infection prevention and control became paramount during the pandemic. This emphasis on infection control practices, such as hand hygiene and wound dressing changes, influenced wound care protocols. Healthcare providers implemented stricter measures to prevent wound infections, leading to changes in wound care practices and products. The pandemic accelerated the adoption of telemedicine and remote monitoring technologies. This shift allowed healthcare professionals to assess and provide guidance on wound care remotely, reducing the need for in-person visits and minimizing the risk of virus transmission. The pandemic underscored the importance of innovation in wound care. Research and development efforts focused on developing more advanced wound care products, such as antimicrobial dressings and telehealth-integrated wound monitoring devices, to address the unique challenges posed by COVID-19. People became more conscious of wound hygiene and the potential risks associated with untreated wounds. Regulatory agencies in some regions implemented temporary regulatory flexibility measures to expedite the approval and distribution of wound care products that were in high demand during the pandemic, such as personal protective equipment (PPE) and wound dressings.Competitive Landscape
The global wound care market is fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective wound care services. Some of the major companies in global wound management market include XX.Key developments
- In July 2023, Smith & Nephew launched REGENTEN Bio-inductive implant in India. The implant is designed to provide wound care by supporting the natural healing response of the body, and facilitating the growth of tendon tissue
- In June 2023, Baxter International Inc. launched Progressa+ Next Gen ICU Bed to assist in addressing complex and critical care demands. It takes into consideration the need of critical care including wound care for patients
- In February 2023, Coloplast Corporation launched Luja, a male catheter, for reducing the risk of urinary tract infections. It has been designed to provide continence care, thus making expansion in the global market of wound care
- In February 2023, URGO Medical introduced Legs Go which is the latest leg ulcer patient program. The program has been designed for understanding the condition of legs of patients, thus constituting a positive impact on wound healing
- In January 2023, Convatec Group PLC announced the launch of ConvaFoam, an advanced foam dressing for addressing the requirements of patients and healthcare providers in skin protection, and wound management
- In March 2023, Bactiguard launched Wound Care line in UK and Ireland in partnership with GS Medical, full-service medical sales and Distribution Company, and Quintess Medical, their partner. The partnership will not only expand the patient and end-user base for Bactiguard's line of wound care products, but it will also solidify Bactiguard's position in the wound care industry.
- In March 2023, B. Braun Medical Inc. announced its acquisition of the Epitech Group, a leading provider of wound care products. The deal is expected to strengthen B. Braun’s presence in the wound care market and expand its portfolio of products.
- In April 2023, Acelity L.P. Inc. announced its acquisition of Systagenix Wound Management Ltd., a leading provider of advanced wound care products. The deal is valued at $485 million and is expected to expand Acelity’s portfolio of wound care products.
Companies Covered in this report:
Smith & Nephew plc, B. Braun Melsungen AG, Johnson and Johnson (Ethicon), Baxter International Inc., 3M, Medtronic Inc, Becton, Dickinson and Company, Medline Industries, Med-Con (Thailand) Co., Ltd., Nipro Corporation, Zimmer Biomet, Cardinal Health Inc, Molnlycke Health Care AB, Convatec Group PLC, Urgo Medical, Coloplast Corporation, Advancis Medical, Essity AB, Integra LifeSciences, Organogenesis Inc.Considered in this report
- Geography: Global
- Historic year: 2017
- Base year: 2022
- Estimated year: 2023
- Forecast year: 2028
Aspects covered in this report
- Global Wound Care Management market with its value and forecast along with its segments
- Region-wise Wound Care Management market analysis
- Various drivers and challenges
- On-going trends and developments
- Top profiled companies
- Strategic recommendation
Regions & Countries covered in the report:
- North America (United States, Canada, Mexico)
- Europe (Germany, United Kingdom, France, Spain, Italy, Russia)
- Asia-Pacific (China, Japan, India, Australia, South Korea)
- South America (Brazil, Argentina, Colombia)
- Middle East & Africa (United Arab Emirates, Saudi Arabia, South Africa)
By Product Type:
- Advanced Wound Care Product
- Surgical Wound Care Product
- Traditional Wound care Product
By Wound Type:
- Surgical& Traumatic Wounds
- Diabetic Foot ulcers
- Pressure ulcers
- Venous leg Ulcers
- Burns & other Wounds
By End User:
- Hospitals and Clinics
- Long-term Patient care
- Home Care Settings
- Other End Users